|
|
||||||||
and Heme Oxygenase-11From the Departments of Neurosurgery, 2Ophthalmology and Visual Sciences, and 3Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri.
PURPOSE. To determine whether the duration of ischemic tolerance in the retina could be extended by repetitive presentations of the preconditioning stimulus and to begin to elucidate the mechanistic underpinnings of the resultant novel phenotype.
METHODS. Adult male Swiss-Webster ND4 mice were repeatedly preconditioned with systemic hypoxia (RHP) over 12 days; 4 weeks later, the mice were subjected to 30 minutes of unilateral retinal ischemia. Protection was quantified morphologically and functionally 1 week after ischemia by histologic analyses and scotopic electroretinography, respectively. Temporal expression patterns of hypoxia-inducible factor (HIF)-1
and heme oxygenase (HO)-1 were measured in response to RHP and after retinal ischemia by immunoblot analysis and immunohistochemistry.
RESULTS. Morphologic and functional protection against ischemia-induced reductions in retinal layer thicknesses and layer cell counts, and a- and b-wave amplitudes, was documented for at least 4 weeks after RHP. There was no evidence of tissue injury or dysfunction by RHP alone. Temporally associated with this period of long-term tolerance (LTT) to retinal ischemia were sustained increases in retinal levels of HIF-1
and HO-1 protein lasting at least 1 and 4 weeks, respectively, after the last RHP stimulus.
CONCLUSIONS. A novel form of sustained retinal ischemic tolerance is described, wherein endogenous adaptive responses triggered by repeated hypoxia afford protection against injury many weeks after the preconditioning stimulus. HIF-1
-mediated, long-lasting increases in retinal HO-1 expression may contribute to the LTT phenotype. Further elucidation of the genetic and molecular basis of such adaptive plasticity could provide therapeutic targets for preventing and/or treating a variety of ischemic retinopathies.
This article has been cited by other articles:
![]() |
S. Joly, C. Lange, M. Thiersch, M. Samardzija, and C. Grimm Leukemia Inhibitory Factor Extends the Lifespan of Injured Photoreceptors In Vivo J. Neurosci., December 17, 2008; 28(51): 13765 - 13774. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Berkowitz, M. Gradianu, S. Schafer, Y. Jin, A. Porchia, R. Iezzi, and R. Roberts Ionic Dysregulatory Phenotyping of Pathologic Retinal Thinning with Manganese-Enhanced MRI Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3178 - 3184. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Brantley Jr, S. Jain, E. E. Barr, E. M. Johnson Jr, and J. Milbrandt Neurturin-Mediated Ret Activation Is Required for Retinal Function J. Neurosci., April 16, 2008; 28(16): 4123 - 4135. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Forooghian, R. Razavi, and L. Timms Hypoxia-inducible factor expression in human RPE cells Br. J. Ophthalmol., October 1, 2007; 91(10): 1406 - 1410. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |